Section 12 AAC 52.865 - Reporting and reviewing PDMP information(a) Unless excused from reporting under AS 17.30.200(t), a pharmacist-in-charge must submit information on behalf of the employing pharmacy required under AS 17.30.200(b) and other information required by the American Society of Automation in Pharmacy (ASAP), as specified in the Appriss Health, PMP AWARxE Data Submission Guide for Dispensers, Alaska Prescription Drug Monitoring Program, Version 2.2, April 2021, adopted by reference. If the pharmacist-in-charge is not present, a pharmacist or third-party vendor may report on behalf of the pharmacy. A practitioner, practitioner's delegate, or third-party vendor may also report on behalf of the practitioner.(b) Unless excused from reporting under AS 17.30.200(t), a pharmacist or practitioner required to submit information under AS 17.30.200(b) must submit the information to the PDMP daily. Information regarding a schedule II, III, or IV controlled substance prescribed by a veterinarian and dispensed by a pharmacist must be submitted by the pharmacist. Nothing affects the inapplicability of this section to veterinarians under AS 17.30.200(u).(c) If the pharmacist or practitioner did not dispense any Schedule II, III, or IV controlled substances on the previous day, the pharmacist or practitioner must submit a zero report.(d) The time computation under 12 AAC 02.920(b) applies to a submission of information under AS 17.30.200(b) and this section.(e) For the purposes of AS 17.30.200(b)(1), "other appropriate identifier" and for the purposes of17.30.200(b)(8), "other appropriate identifying information" mean the state-issued license number of the prescribing practitioner and state-issued license number of the dispensing pharmacist or practitioner.(f) Not later than 72 hours after discovering an error in information submitted under AS 17.30.200(b), a pharmacist or practitioner required to submit the information under AS 17.30.200(b) must notify the PDMP administrator. The time computation under 12 AAC 02.920(b) applies to a submission of information correcting an error in information submitted under AS 17.30.200(b).(g) Unless excused from reporting under AS 17.30.200(t), or a waiver is granted under 12 AAC 52.870, a pharmacist or practitioner required to submit information under AS 17.30.200(b) must submit the information to the PDMP electronically through the website provided by the board.(h) Unless excused from reviewing the PDMP under AS 17.30.200(k)(4)(A) - (B), a practitioner, but not a pharmacist, must review the information in the PDMP to check a patient's prescription records before dispensing, prescribing, or administering a schedule II or III controlled substance under federal law.Eff. 12/29/2011, Register 200; am 6/7/2018, Register 226, July 2018; am 12/28/2022, Register 244, January 2023; am 1/19/2024, Register 249, April 2024As of Register 233 (April 2020), the regulations attorney made a technical revision under AS 44.62.125(b)(6), to 12 AAC 52.865(b).
In 2018 the revisor of statutes, acting under AS 01.05.031, rearranged the subsections in AS 17.30.200. As a result, the subsection formerly designated as AS 17.30.200(o) is now designated as AS 17.30.200(n). As of Register 237 (April 2021), the regulations attorney made a conforming technical revision under AS 44.62.125(b)(6), to 12 AAC 44.445(d), so that the cross-reference now cites AS 17.30.200(n), formerly designated AS 17.30.200(o).
The regulations attorney made a technical revision under AS 44.62.125. to set out a cross-reference to AS 17.30.200(u). Sec. 5, ch. 14, SLA 2023 originally enacted the statutory subsection as AS 17.30.200(v). but the revisor of statutes, acting under AS 01.05.031, is expected upon final codification to assign that statutory material to AS 17.30.200(u), and assign AS 17.30.200(v) to the current section-specific definitions.
Authority:AS 08.80.005
AS 08.80.030
AS 17.30.200